Brexit, US stimulus and the roll-out of vaccines are dominating investors’ thoughts
Thursday 10 Dec 2020 Author: Tom Sieber

There is plenty for investors to think about as we approach the end of a tumultuous year. For UK stocks the most significant remains Brexit and the prospects for a deal.

As we write talks were going to the wire. However, an important point to remember is that even if a deal is secured it will be quite a limited one and it will still mean extra checks and regulation on goods flowing from the EU to the UK and vice-versa. This raises the prospect of disruption when the transition period ends in January.

Whether this might have an impact on the roll-out of vaccines – key to a reopening of the economy – could become a more pressing story with 90-year-old Margaret Keenan in Coventry becoming the first person in the world to receive the Pfizer vaccine.

The other big politics meets economics story is the bi-partisan stimulus package in the US with suggestions an agreement could come soon. This would likely provide stocks with a further catalyst although some kind of support has arguably already been priced in by the market as US equities soared to new record highs as a weak jobs report (4 Dec) was seen as increasing the pressure to get a stimulus deal signed off.

‹ Previous2020-12-10Next ›